Cleared Traditional

K200862 - Feelix Stethoscope

K200862 is an FDA 510(k) clearance for Feelix Stethoscope, manufactured by Sonavi Labs, Inc.. The device is a Class 2 Cardiovascular device with product code DQD cleared through the Traditional 510(k) pathway after a 166-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2020
Decision
166d
Days
Class 2
Risk

K200862 is an FDA 510(k) clearance for the Feelix Stethoscope. Classified as Stethoscope, Electronic (product code DQD), Class II - Special Controls.

Submitted by Sonavi Labs, Inc. (Baltimore, US). The FDA issued a Cleared decision on September 14, 2020 after a review of 166 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1875 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Sonavi Labs, Inc. devices

FDA 510(k) Submission Details - K200862

510(k) Number K200862 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 01, 2020
Decision Date September 14, 2020
Days to Decision 166 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
41d slower than avg
Panel avg: 125d · This submission: 166d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQD Device Classification - Class 2, Special Controls

Product Code DQD Stethoscope, Electronic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1875
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQD Stethoscope, Electronic

All 105
Devices cleared under the same product code (DQD) and FDA review panel - the closest regulatory comparables to K200862.
eKuore One Wireless Electronic Interface for stethoscope
K201742 · Chip Ideas Electronics S.L. · Nov 2020
eKuore Pro Series
K203007 · Chip Ideas Electronics S.L. · Oct 2020
Stethee Pro 1, Stethee Pro Software System
K193631 · M3Dicine Pty , Ltd. · Oct 2020
HD Steth
K201299 · Hd Medical, Inc. · Jul 2020
Eko CORE
K200776 · Eko Devices, Inc. · Apr 2020
Electronic Stethoscope
K191667 · Hefei Mintti Medical Technology Co., Ltd. China · Dec 2019